Clinical Trial Update: Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating glucose-lowering strategies in patients with heart failure shows completed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-06-18